Insider Selling: HealthEquity, Inc. (NASDAQ:HQY) Vice Chairman Sells $2,795,100.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Stephen Neeleman also recently made the following trade(s):

• On Friday, June 7th, Stephen Neeleman sold 2,080 shares of HealthEquity stock. The stock was sold at an average price of $85.01, for a total value of $176,820.80.
• On Tuesday, June 4th, Stephen Neeleman sold 400 shares of HealthEquity stock. The stock was sold at an average price of $85.00, for a total value of $34,000.00.

HealthEquity Stock Up 0.1 %

HQY stock opened at $78.48 on Thursday. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. The firm has a market cap of $6.83 billion, a PE ratio of 85.30, a price-to-earnings-growth ratio of 1.34 and a beta of 0.57. The business has a 50 day moving average of $81.44 and a 200 day moving average of $80.14.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, June 3rd. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. The company had revenue of $287.60 million during the quarter, compared to analyst estimates of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. On average, research analysts forecast that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of several research analyst reports. KeyCorp increased their price objective on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Wells Fargo & Company increased their target price on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research report on Thursday, June 20th. Raymond James increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Robert W. Baird increased their target price on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research report on Tuesday, June 4th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $101.67.

Institutional Trading of HealthEquity

A number of institutional investors and hedge funds have recently modified their holdings of HQY. Cape Investment Advisory Inc. bought a new stake in shares of HealthEquity in the 4th quarter worth $27,000. Rise Advisors LLC bought a new stake in shares of HealthEquity in the 1st quarter worth $28,000. McGlone Suttner Wealth Management Inc. bought a new stake in shares of HealthEquity in the 4th quarter worth $29,000. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the 2nd quarter worth $35,000. Finally, YHB Investment Advisors Inc. purchased a new position in shares of HealthEquity in the 1st quarter worth $40,000. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.